Prescribing the right medication at the right dose is not always straightforward. Two patients can receive the same therapy and experience entirely different results—one may respond well, while another suffers side effects or no benefit at all.
Pharmacogenomic (PGx) testing bridges that gap by identifying how a patient’s genes influence drug metabolism, absorption, and effectiveness. By understanding these genetic variations, providers can personalize prescriptions, minimize trial-and-error approaches, and improve both safety and efficacy.
How PGx Testing Works
PGx testing analyzes variations in genes that encode drug-metabolizing enzymes, transporters, and receptors. When certain variants are present, they can alter how medications are processed in the body.
For example:
Variations in the CYP2D6 or CYP2C19 genes can change how patients metabolize antidepressants, opioids, or cardiac medications.
Mutations in SLCO1B1 may influence statin metabolism and risk for muscle toxicity.
Differences in VKORC1 and CYP2C9 affect how patients respond to anticoagulants like warfarin.
By analyzing these markers, providers can predict response before therapy begins and select the safest, most effective option from the start.
Clinical Benefits of Pharmacogenomic Testing
- Improved Safety: Identifies patients at risk of adverse drug reactions, reducing hospitalizations and complications.
- Optimized Efficacy: Helps providers choose medications and doses most likely to work for each individual.
- Reduced Costs: Minimizes trial-and-error prescribing, avoiding unnecessary medication changes or side effects.
- Enhanced Patient Confidence: Patients gain reassurance that their treatment plan is guided by data unique to them.
Best Practices in Toxicology Testing
Reliable toxicology testing depends on a combination of accurate methods, clear reporting, and clinical context. Providers seeking toxicology partners should look for:
CLIA-certified laboratories with validated assays for common therapeutic and illicit drugs.
Comprehensive test menus including opioids, benzodiazepines, stimulants, cannabinoids, and alcohol metabolites.
Fast turnaround times to support clinical decision-making.
Reports that are concise and clinically actionable, integrating seamlessly into electronic health records (EHRs).
Partnering with a quality laboratory ensures that toxicology data are not just collected, but used meaningfully to improve patient safety.
PGx Testing at Proteus Genomics Labs
At Proteus Genomics Labs, our PGx services are designed to deliver actionable insights with clinical clarity. Testing includes:
Comprehensive panels covering cardiovascular, psychiatric, and pain-management medications.
Clear, easy-to-interpret reports highlighting gene-drug interactions and recommended adjustments.
Rapid turnaround times and seamless integration with provider workflows.
Dedicated support from our laboratory and client services teams for implementation and interpretation.
Every test is performed under CLIA-certified standards, ensuring accuracy, reproducibility, and compliance with clinical best practices.
Integrating PGx Into Everyday Care
Pharmacogenomic testing is no longer limited to academic research centers. Increasingly, it’s part of routine clinical practice—especially in behavioral health, cardiology, pain management, and primary care.
By incorporating PGx insights into prescribing decisions, providers can offer more personalized, data-driven care that improves safety and strengthens trust.
Pharmacogenomics transforms how medications are prescribed—bringing precision, safety, and personalization to everyday medicine.
At Proteus Genomics Labs, we’re proud to support providers with accurate, clinically actionable PGx testing that helps deliver better outcomes for every patient.
